Navigation Links
‘Rip Van Winkle’ Treatment May Curb Cancer Cell Growh

A new research supports the theory that bringing about senescence in aged cells may help curb proliferation of tumor cells//.

Inducing senescence in aged cells may be sufficient to guard against spontaneous cancer development, according to a paper published online this week in European Molecular Biology Organization (EMBO reports). It was previously unknown whether cellular senescence or programmed cell death – apoptosis – was the more important safeguard mechanism for suppressing tumors arising from dysfunctional telomeres.

Aged cells have abnormal chromosomes with dysfunctional telomeres – shorter ends – that can promote tumorigenesis in the absence of the tumor suppressor p53, and may be related to the higher incidence of cancer in older individuals. However, in the presence of p53, dysfunctional telomeres can induce a permanent arrest of cell growth, known as senescence.

Sandy Chang and colleagues studied mutant mice with dysfunctional telomeres and copies of the p53 gene that cannot initiate p53-dependent apoptosis but can execute p53-mediated senescence.

The authors found that activating the senescence pathway was sufficient to suppress spontaneous tumorigenesis.

Their findings suggest that, by halting cellular proliferation, p53-mediated senescence may act as an important tumour suppressor mechanism in aged cells.

Source-Eurekalert
NN
'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
(Date:12/2/2008)... Need to Reduce Disparities in Meningococcal Vacci...THESDA, Md., Dec. 2 The National....P. (Share. Teach. Outreach. Protect.) Meningiti...ading medical and advocacy organizations, recently...ingococcal vaccination rates and to reduce immuniz...
(Date:12/2/2008)...le to seniors , , DETROIT, Dec. 2 /PRNewswi...dding acupuncture and chiropractic services to its...ntage members beginning January 1, 2009. HAP,s gro...es Medicare beneficiaries to choose activities and...heir wallets. , , HAP offers a Flexible He...
(Date:12/2/2008)...y with no additional radiation, minimal cost , ...orectal cancer and osteoporosis are very different...tely detect, a new study says. , A virtual colo...s in the large intestine. A presentation, expected...g of the Radiological Society of North America, wi...
(Date:12/2/2008)...developed a prototype blood scanner that can find ...of the disease, potentially allowing for earlier t...ival. , The system based on MagArray biodetectio...lood serum sample in less than an hour, and with m...evices. In fact, the device, which uses magnetic n...
Breaking Medicine News(10 mins):Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 2Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 3Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 4Health News:HAP Expands Medicare Advantage Options to Include Acupuncture and Chiropractic Services 2Health News:HAP Expands Medicare Advantage Options to Include Acupuncture and Chiropractic Services 3Health News:CT Colonography Screens for Cancer, Osteoporosis 2Health News:Stanford blood scanner detects even faint indicators of cancer 2Health News:Stanford blood scanner detects even faint indicators of cancer 3
...ska, sharing some winter skincare tips would help ...For those of us in Europe and the US, winter can b.... The experts say you should always use a mild, su...u spend in the bath or shower to no more than ten ...
...vere periodontal disease than non-diabetic pregnan...riodontology.// Researchers from the University of...13 type 1 diabetic and 20 non-diabetic women in th...ine the effects of periodontal infection on the co...
...ersity students, and there is significant incidenc...rcing,"// said Dr. Lester B. Mayers of the Pace Un...Medicine and the lead author of the study. A surv...s revealed that more than one-half had some type o...
...roducts more than twice a week can obviously reduc...nsuming cooked tomatoes was particularly beneficia...arly eating tomato sauce, ketchup and other tomato...er risk by as much as 30 percent.// Dr. Edward Gio...
Other Medicine News:
(Date:11/25/2008)... 25 Pharmacyclics, Inc.,...y has completed a Phase 1,clinical trial with PCI...-molecule Factor VIIa inhibitor. The trial was con...uate the safety and pharmacologic effect of,PCI-2...d in a linear dose,response in the International ...
(Date:11/25/2008)...ewswire-FirstCall/ -- CardioVascular,BioTherapeut...day that it has,dosed the first patient in North ...al trial to treat patients with severe coronary he...tment of CORonary heart Disease) trial will includ...ed doses in approximately 120,patients with sever...
(Date:11/24/2008)...24 Domino,s Pizza (NYSE: DPZ ), ... gearing up to raise dough for,the kids of St. Ju...nnual,Thanks and Giving campaign. Domino,s custom...at point of purchase to benefit the children of St...the phone or when ordering online at, www.dominos...
(Date:11/24/2008)...Cancer Awareness Month , , Oak Brook, Ill.,...Society for Gastrointestinal Endoscopy (ASGE) and ...p this November to raise awareness about pancreati... the resources that are available for them. , ... of cancer deaths in the U.S. In 2008, an estimate...
Breaking Medicine Technology:Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 2ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 5ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 6AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 1AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 2AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 3AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 4Houston Heart Surgeon Elected Vice President of Guatemala 5534 1Houston Heart Surgeon Elected Vice President of Guatemala 5534 2Fragile X Foundations Sign Merger Agreement 5532 1Fragile X Foundations Sign Merger Agreement 5532 2Fragile X Foundations Sign Merger Agreement 5532 3Baron 26 Budd P C Announces 243 6 Million Settlement in California Asbestos Lawsuit 5530 1Baron 26 Budd P C Announces 243 6 Million Settlement in California Asbestos Lawsuit 5530 2
...d at the American College of,Cardiology,s Scientif...RNewswire-FirstCall/ -- CV,Therapeutics, Inc. anno...m the MERLIN TIMI-36 study of ranolazine shows the... patients on ranolazine.,The study did not meet th...the company,s special protocol assessment,agreemen...
...s Across the Genome From 242,Patients and Identifi...astic Leukemia, Suggesting New Targets for Improve...ire/ -- Investigators at,St. Jude Children,s Resea...d mutations that contribute to the formation of pe...st common cancer in,children. The discovery not on...
Other Medicine Technology:CV Therapeutics Announces Topline MERLIN TIMI-36 Results 2CV Therapeutics Announces Topline MERLIN TIMI-36 Results 3Major Gene Study Uncovers Secrets of Leukemia 2Major Gene Study Uncovers Secrets of Leukemia 3
For the quantitative measurement of CKMB, Myoglobin, and Troponin-I in human serum.
According to the National Academy of Clinical Biochemistry guidelines for the use of cardiac markers in coronary artery disease, troponin I is definitive of acute myocardial infarction. The new Acces
A fluorogenic enzyme-linked immunoassay (ELISA) for the quantitative measurement of myoglobin in human serum or plasma aiding in the diagnosis of acute myocardial infarction (AMI). Features : Dry che
Clinical marker immunoassay kit for detection of Myoglobin.
Medicine Products: